Technology and Equipment

Manufacturing bottlenecks remain a key hurdle in CAR-T therapy. Can automation and digital integration change that?

How connecting the data dots can lead to better development and clinical trals. 

How the right partnerships are helping streamline CGT manufacturing through robotics and digital tools.

AI is set to be a key disruptor in the pharma industry. Here are two perspectives on how it could change drug development.

Here’s why the Cell and Gene Therapy Catapult is excited about the potential of digital twin technology.

Who will be the grand winner of our 2024 Innovation Awards?

Accelerating the progress of cell and gene therapies with decentralized trials and other innovative approaches.

AI helps make preclinical decisions faster, but stakeholders remain cautious. We asked an expert from Elsevier for their views on the challenges.

Understanding the role of spatially offset Raman spectroscopy in identifying raw materials, counterfeit medicines, and more.